1076465

Bromazepam

United States Pharmacopeia (USP) Reference Standard

• 동의어(들): 7-Bromo-5-(2-pyridyl)-3H-1,4-benzodiaxepin-2(1H)-one
• 실험식(Hill 표기법): C₁₄H₁₀BrN₃O
• CAS Number: 1812-30-2
• Molecular Weight: 316.15
• MDL number: MFCD00057902
• UNSPSC 코드: 41116107
• PubChem Substance ID: 329749131
• NACRES: NA.24

속성

• Grade: pharmaceutical primary standard
• API family: bromazepam
• 제조업체/상표: USP
• 약물 제어: regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)
• 응용 분야: pharmaceutical (small molecule)
• 형식: neat
• SMILES string: O=C(CN=C1C2=CC=CC=N2)NC3=C1C=C(Br)C=C3
• InChI: 1S/C14H10BrN3O/c15-9-4-5-11-10(7-9)14(17-8-13(19)18-11)12-3-1-2-6-16-12/h1-7H,8H2,(H,18,19)
• InChI key: VMIYHDSEFNYJSL-UHFFFAOYSA-N
• 유전자 정보: human ... GABRA2(2555)

설명

일반 설명

Bromazepam belongs to the 1,4-benzodiazepine class of compounds. It is a type of psychotropic drug, which finds therapeutic applications as an anti-anxiety agent.

애플리케이션

Bromazepam may be used as a standard in the quantitative determination of bromazepam in biosamples like human plasma using high performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS-MS).

분석 메모

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

기타 정보

Sales restrictions may apply.

안전성 정보

• 픽토그램: GHS07
• 신호어: Warning
• 유해 및 위험 성명서: H302,H315,H319,H335
• 예방조치 성명서: P301 + P312 + P330 - P305 + P351 + P338
• Hazard Classifications: Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• 표적 기관: Respiratory system
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable